Companies Dominating the Oxycodone Landscape
- Nektar Therapeutics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Boehringer Ingelheim GmbH
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc.
- Esteve Pharmaceuticals, S.A.
- Validus Pharmaceuticals LLC
- Teva Pharmaceutical Industries Ltd.
- Siemens Healthcare GmbH
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Oxycodone Market in 2025 is evaluated at USD 11.01 billion.
The global market size was worth around USD 10.39 billion in 2024 and is set to register a CAGR of more than 7.4%, exceeding USD 26.28 billion revenue by 2037.
Asia Pacific is on pace to accumulate USD 9.2 billion by 2037, owing to growing aged population and increasing cancer rates, requiring oxycodone for treatment.
The major players in the market include Nektar Therapeutics, Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Esteve Pharmaceuticals, S.A., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Siemens Healthcare GmbH.
